12-Month Stability of Diurnal IOP Control on Cosopt

NCT00379834 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-02-10

Study results available
· View outcomes & findings →

Summary

To determine the stability of diurnal intraocular pressure in eyes with glaucoma treated with Cosopt

Conditions

Interventions

DRUG

Cosopt

Cosopt twice daily in both eyes

Sponsors & Collaborators

  • West Virginia University

    lead OTHER

Principal Investigators

  • Anthony D Realini, MD · West Virginia University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-04-30
Completion
2008-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00379834 on ClinicalTrials.gov